The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $2,785,229 in first-year total cost, median $716,589.
Most frequent study sections
- HIV Comorbidities and Clinical Studies Study Section[HCCS]1
- Pediatrics Study Section[CHHD-A]1
- Special Emphasis Panel[ZRG1 AARR-J (55)]1
- Special Emphasis Panel[ZRG1 AARR-P (02)]1
Most frequent institutions
- JOHNS HOPKINS UNIVERSITY1
- NAVIGEN, INC.1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- UNIVERSITY OF WASHINGTON1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2019 | In vivo Evaluation of Safety and Pharmacology of the Sustained Release Formulation of Dolutegravir in Pre-Conception and Early Stages of Pregnancy in Animal Models1R01HD100584-01 | KOVAROVA, MARTINAPARNELL, SCOTT | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $777,388 | CHHD |
| 2019 | Acceptability of Sustained-Release Antiretrovirals for Treatment in the US and sub-Saharan Africa1R01MH121424-01A1 | GRAHAM, SUSAN MARIESIMONI, JANE M. | UNIVERSITY OF WASHINGTON, WA | $525,780 | HCCS |
| 2017 | Depot formulation of a D-peptide HIV entry inhibitor1R01AI127092-01A1 | MUELLER, ALAN LWELCH, BRETT D | NAVIGEN, INC., UT | $826,272 | ZRG1 |
| 2017 | Long acting NRTI therapies for HIV1R01AI134091-01 | FREEL MEYERS, CAREN L.RANNARD, STEVE | JOHNS HOPKINS UNIVERSITY, MD | $655,789 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.